Skip to main content

Saliva is a reliable tool to detect SARS-CoV-2.

Azzi L, Carcano G, Gianfagna F, Grossi P, Gasperina DD, Genoni A, Fasano M, Sessa F, Tettamanti L, Carinci F, Maurino V, Rossi A, Tagliabue A, Baj A

Publication: J Infect (2020)PMID: 32298676View on PubMed

Purpose

This paper investigated the use of salivary specimens for detection of SARS-CoV-2, the virus that causes the novel 2019 coronavirus disease (COVID, COVID-19, COVID19) in patients with SARS-CoV-2 positive nasopharyngeal specimens and investigated if SARS-CoV-2 was detected in a patient’s salivary specimen after the nasopharyngeal specimen became negative. The effect of period since onset of symptoms, lactate dehydrogenase (LDH) levels, ultrasensitive C-reactive protein (us-CRP) levels, patient age, patient sex, drug intake, and the presence of comorbidities on SARS-CoV-2 cycle threshold (CT) value was also investigated.

Conclusion

SARS-CoV-2 was detected in the initial saliva specimen from all 25 patients. The authors state there was no effect of period since onset of symptoms on salivary SARS-CoV-2 CT observed; however, regression analysis showed salivary RT-PCR values for SARS-CoV-2 were inversely correlated with LDH but not with us-CRP levels, patient age, patient sex, drug intake, or the presence of comorbidities. The authors state there were no relevant differences in SARS-CoV-2 CT between the first and second salivary collection. Importantly, the authors report positive salivary specimens for 2 or more days after the nasopharyngeal specimen became negative.

Studies (1)

Purpose

This study investigated the use of salivary specimens for detection of SARS-CoV-2 in patients with SARS-CoV-2 positive nasopharyngeal specimens and investigated if SARS-CoV-2 was detected in a patient’s salivary specimen after the nasopharyngeal specimen became negative. The effects of period since onset of symptoms, LDH levels, us-CRP levels, patient age, patient sex, drug intake, and the presence of comorbidities on SARS-CoV-2 CT value was also investigated. Saliva was collected using the drooling method or intraorally using a pipette from 25 hospitalized patients (17 male and 8 female, age 39-85) with severe or very severe infections with SARS-CoV-2 diagnosed by nasopharyngeal swabs. A second saliva specimen was collected from eight patients 4 days later. Saliva was resuspended in PBS and RNA was extracted using the QIAmp Viral RNA Mini Kit and subjected to one-step RT-PCR using the Luna Universal qPCR Master Mix and primer for the 5’UTR of SARS-CoV-2. Specimens were classified as highly positive or low positive based on having a CT value below or above the median CT, respectively. Method of us-CRP and LDH determination was not specified.

Summary of Findings

SARS-CoV-2 was detected in the initial saliva specimen from all 25 patients. The authors state there was no effect of period since onset of symptoms on salivary CT observed; however, regression analysis showed salivary RT-PCR values for SARS-CoV-2 were inversely correlated with LDH (β=-0.02, P= 0.04) and average LDH levels were significantly lower in male patients than female patients (304.3 versus 400.6, P=0.025). SARS-CoV-2 CT values were not significantly associated with us-CRP levels, patient age, patient sex, drug (anticoagulants, ACE-inhibitors, or statins) intake, or the presence of comorbidities such as dyslipidemia, hypertension, or obesity. The authors state there were no relevant differences in SARS-CoV-2 CT between the first and second salivary collection. Importantly, the authors report positive salivary specimens for 2 or more days after the nasopharyngeal specimen became negative.

  • Biospecimens

    FluidSaliva
    CellNasopharynx
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Pneumonia/Respiratory Infection
  • Platforms

    RNAReal-time qRT-PCR
    ProteinClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionOther drugs
    ACE-inhibitors
    Anticoagulants
    Statins
    PreaquisitionPatient age
    39-85 years old
    PreaquisitionPatient gender
    Female
    Male
    PreaquisitionPrior patient medical condition
    Existing dyslipidemia, hypertension, or obesity
    Biospecimen AcquisitionBiospecimen location
    Nasopharynx
    Saliva
    Biospecimen AcquisitionTime of biospecimen collection
    Current positive nasopharyngeal swab
    Day nasopharyngeal swab converted to negative
    Two days after nasopharyngeal swab converted to negative
    Unspecified duration since onset of symptoms
    Real-time qRT-PCR SpecificTargeted nucleic acid
    SARS-CoV-2